Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,714.00    -22.00 (-1.27%)
Bid:
1,716.00
Ask:
1,722.00
Spread: 6.00 (0.35%)
Market Cap: £504.80m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Post Close Trading Update

13 Oct 2021 07:00

RNS Number : 8651O
Avon Protection PLC
13 October 2021
 

13 October 2021

Avon Protection plc

Post Close Trading Update

 

Avon Protection plc ("Avon" or the "Group") today provides the following post close trading update for its financial year ended 30 September 2021 ("FY21").

 

Trading update

Avon has continued to see good commercial momentum in the second half of FY21, with order intake for the year of c.$280 million. This represents total year-on-year order growth of 34% and growth of 15% excluding Team Wendy. As a result, the Group has carried a strong closing order book of $141 million into the new financial year ("FY22"), up 39% on 30 September 2020. This momentum underpins confidence in the Group's growth expectations for FY22.

 

The Group expects to report revenue of $250 million for FY21 (2020: $213.6 million), which is within the range indicated in our trading update of 13 August 2021. This includes a Team Wendy contribution of $41 million from the first 11 months of ownership, in line with expectations at the time of acquisition.

 

As expected, we have seen revenue growth in our First Responder business and Military respiratory portfolio, offset by declines in Military ballistic revenue due to the previously announced delays. Overall, Military revenue is expected to decline by 3% to $149 million with respiratory revenue growth of 10% being offset by a 31% decline in Military ballistic revenues. First Responder revenues are expected to have increased by 2% to $61 million, against a strong comparator in 2020, driven by very encouraging growth in our ballistic protection portfolio.

 

Trading profitability in the remainder of FY21 was in line with the expectations set out in the August trading update. The Group will however recognise one-off, non-cash, ballistic protection inventory adjustments, which are expected to reduce the reported adjusted EBITDA margin for FY21 to between 15% and 16%.

 

Cash conversion has come through more strongly than anticipated at the time of the August trading update. As a result, we expect FY21 reported cash conversion of c.80% and net debt before lease liabilities of $27 million at 30 September 2021.

 

Commenting, Paul McDonald, Chief Executive Officer, said:

"We have made considerable commercial progress over the last 12 months in continuing to build a broader portfolio of contracts, increasing our pipeline of opportunities and making record levels of investment in the business.

 

We carry significant commercial momentum into FY22, which will also benefit from a strong ramp-up in body armor, as well as the strengthened senior management, processes and infrastructure we have put in place over the past year whilst navigating the ongoing disruption related to Covid through our supply chains.

 

We remain well set for growth in FY22 and beyond and are as confident as ever about the medium-term prospects of Avon Protection. This is underpinned by a strong order book, a growing and visible contract pipeline and our global market leading positions in respiratory and ballistic protection."

 

Notice of Results

The Group will release its results for the year ended 30 September 2021 on 23 November 2021.

 

For further enquiries, please contact:

 

Avon Protection plc

Paul McDonald, Chief Executive Officer

01225 896 848

Nick Keveth, Chief Financial Officer

Rachel Stevens, Director of Investor Relations

MHP Communications

Andrew Jaques

0203 128 8570

Charlie Barker

avonprotection@mhpc.com

Pete Lambie

 

Legal Entity Identifier: 213800JM1AN62REBWA71

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

Note to editors: 

Avon Protection plc is listed on the London Stock Exchange (LSE: AVON) and is an innovative technology group, which designs and produces life critical personal protection systems to maximise the performance and capabilities of its customers, with leading positions in the respiratory and ballistic protection markets for the world's militaries and first responders.

For further information, please visit our website www.avon-protection-plc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFETIDLFLIL
Date   Source Headline
21st Jan 20097:00 amRNSAGM & IMS
16th Jan 20097:00 amRNSDirector/PDMR Shareholding
8th Jan 200912:36 pmRNSGrant of Awards - Employee Share Plans
5th Jan 20095:11 pmRNSDirector/PDMR Shareholding
18th Dec 20084:20 pmRNSHolding(s) in Company
16th Dec 20082:53 pmRNSAnnual Report and Accounts
8th Dec 20084:27 pmRNSDirector/PDMR Shareholding
3rd Dec 20088:40 amRNSDirector/PDMR Shareholding
1st Dec 20084:09 pmRNSDirector/PDMR Shareholding
28th Nov 200810:28 amRNSDirector/PDMR Shareholding
27th Nov 20086:05 pmRNSDirector/PDMR Shareholding
27th Nov 20085:50 pmRNSDirector/PDMR Shareholding
27th Nov 20085:40 pmRNSDirector/PDMR Shareholding
27th Nov 20085:35 pmRNSDirector/PDMR Shareholding
27th Nov 20087:00 amRNSFinal Results
19th Nov 200812:00 pmRNSNotice of Results
10th Nov 200812:15 pmRNSSale of UK Mixing Facility
23rd Oct 20089:34 amRNSReplacement for Period End Update
23rd Oct 20087:00 amRNSPeriod End Update
28th Aug 20087:00 amRNSContract Win
13th Aug 20083:21 pmRNSBlocklisting Interim Review
8th Aug 20087:00 amRNSInterim Management Statement
17th Jul 20089:33 amRNSDirector/PDMR Shareholding
30th Jun 200811:08 amRNSDirector/PDMR Shareholding
23rd Jun 20089:11 amRNSBoard and Senior Management A
2nd Jun 20082:11 pmRNSDirector/PDMR Shareholding
28th May 20087:00 amRNSInterim Results
19th May 20089:00 amRNSNotice of Results
19th May 20087:00 amRNSContract Award
2nd May 20082:45 pmRNSDirector/PDMR Shareholding
21st Apr 20087:00 amRNSTrading Update
4th Mar 20082:15 pmRNSCompletion of Disposal
18th Feb 20083:47 pmRNSDirector/PDMR Shareholding
8th Feb 20082:38 pmRNSDirector/PDMR Shareholding
8th Feb 20087:00 amRNSDisposal
29th Jan 20082:08 pmRNSDirector/PDMR Shareholding
24th Jan 20084:53 pmRNSAnnual Information Update
24th Jan 20083:07 pmRNSResult of AGM
24th Jan 20082:41 pmRNSDirector/PDMR Shareholding
23rd Jan 200810:30 amRNSAGM Statement
14th Jan 20083:41 pmRNSHolding(s) in Company
11th Jan 20082:12 pmRNSDirector/PDMR Shareholding
9th Jan 20085:05 pmRNSHolding(s) in Company
7th Jan 20082:51 pmRNSTotal Voting Rights
3rd Jan 20083:50 pmRNSHolding(s) in Company
20th Dec 20072:48 pmRNSDirector/PDMR Shareholding
20th Dec 200712:00 pmRNSAnnual Report & Accounts
4th Dec 200712:19 pmRNSTotal Voting Rights
29th Nov 20077:01 amRNSFinal Results
16th Nov 200712:09 pmRNSBlocklisting Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.